Antiatherosclerotic effect of farnesoid X receptor (Q46231561)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 November 2008

Language	Label	Description	Also known as
English	Antiatherosclerotic effect of farnesoid X receptor	scientific article published on 21 November 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

Antiatherosclerotic effect of farnesoid X receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

author name string

Andrea Mencarelli

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

Barbara Renga

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

Eleonora Distrutti

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

Stefano Fiorucci

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

publication date

21 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

296

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

H272-81

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Effects of FXR in foam-cell formation and atherosclerosis development

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

LXR alpha is the dominant regulator of CYP7A1 transcription

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

LXR-dependent gene expression is important for macrophage survival and the innate immune response

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

The farnesoid X-receptor is an essential regulator of cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

ATP-binding cassette transporter AI and its role in HDL formation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Class A scavenger receptors, macrophages, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Identification of a nuclear receptor for bile acids

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Quantitative assessment of atherosclerotic lesions in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Bile acids: natural ligands for an orphan nuclear receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Farnesoid X receptor: from structure to potential clinical applications

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Nuclear receptors in human immune cells: expression and correlations.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

ABC proteins: key molecules for lipid homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01075.2008

21 January 2018

Identifiers

10.1152/AJPHEART.01075.2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19028791

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46231561&oldid=2100568898"